Cargando…

Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19

Background: New tools for the assessment and prediction of the severity of hospitalized COVID-19 patients can help direct limited resources to patients with the greatest need. Circulating levels of calprotectin (S100A8/S100A9) reflect inflammatory activity in multiple conditions, and have been descr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norman, Gary L., Navaz, Sherwin A., Kanthi, Yogendra, Albesa, Roger, Mahler, Michael, Knight, Jason S., Zuo, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221789/ https://www.ncbi.nlm.nih.gov/pubmed/35741134 http://dx.doi.org/10.3390/diagnostics12061324

Ejemplares similares

Neutrophil calprotectin identifies severe pulmonary disease in COVID-19
por: Shi, Hui, et al.
Publicado: (2020)

Autoantibodies stabilize neutrophil extracellular traps in COVID-19
por: Zuo, Yu, et al.
Publicado: (2021)

Endothelial Cell–Activating Antibodies in COVID‐19
por: Shi, Hui, et al.
Publicado: (2022)

The interplay between neutrophils, complement, and microthrombi in COVID-19
por: Zuo, Yu, et al.
Publicado: (2021)

Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection
por: Kim, Jieun, et al.
Publicado: (2017)

Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome
por: Knight, Jason S., et al.
Publicado: (2022)

Circulating calprotectin levels four months after severe and non-severe COVID-19
por: Abu Hussein, N., et al.
Publicado: (2023)

Serum calprotectin as a novel biomarker for severity of COVID-19 disease
por: Kaya, Tezcan, et al.
Publicado: (2021)

Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients
por: Chapuis, Nicolas, et al.
Publicado: (2022)

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
por: Jarlborg, Matthias, et al.
Publicado: (2020)

Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID‐19
por: Lee, Anna, et al.
Publicado: (2021)

Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients
por: Mentzer, Alexander J, et al.
Publicado: (2022)

Calprotectin: from biomarker to biological function
por: Jukic, Almina, et al.
Publicado: (2021)

Faecal calprotectin and gut microbiota do not predict enteropathy in very preterm infants
por: Campeotto, Florence, et al.
Publicado: (2020)

Fecal Calprotectin as a Future Screening Tool for Large Juvenile Polyps
por: Khan, Farah, et al.
Publicado: (2015)

Association of circulating calprotectin with lipid profile in axial spondyloarthritis
por: Genre, Fernanda, et al.
Publicado: (2018)

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
por: Zuo, Yu, et al.
Publicado: (2021)

Calprotectin and SARS-CoV-2: A Brief-Report of the Current Literature
por: Giuffrè, Mauro, et al.
Publicado: (2021)

Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
por: Kamat, Nagesh, et al.
Publicado: (2022)

Neutrophil extracellular traps and thrombosis in COVID-19
por: Zuo, Yu, et al.
Publicado: (2020)

Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series
por: Luis García de Guadiana Romualdo, et al.
Publicado: (2021)

Role of Calprotectin as a Biomarker in Periodontal Disease
por: Wei, Lili, et al.
Publicado: (2019)

Calprotectin as potential novel biomarker in myasthenia gravis
por: Stascheit, Frauke, et al.
Publicado: (2021)

Fecal Calprotectin Elevations Associated with Food Intolerance/Malabsorption Are Significantly Reduced with Targeted Diets
por: Schnedl, Wolfgang J., et al.
Publicado: (2023)

Calprotectin as a Biomarker for Diagnosis and Severity of Acute Noninfectious Anterior Uveitis in Egyptian Patients
por: Abd El Meged Nage, Sara, et al.
Publicado: (2022)

Lipocalin-2 and calprotectin as stool biomarkers for predicting necrotizing enterocolitis in premature neonates
por: Thibault, Marie-Pier, et al.
Publicado: (2021)

COVID–19-associated coagulopathy: An exploration of mechanisms
por: Colling, Meaghan E, et al.
Publicado: (2020)

SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
por: Kumar, Nitin, et al.
Publicado: (2021)

COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19
por: Giuffrè, Mauro, et al.
Publicado: (2020)

A meta-analysis of the association between calprotectin and the severity of COVID-19
por: Mao, Qin, et al.
Publicado: (2022)

Serum calprotectin can indicate current and future severity of COVID‐19
por: Shokri‐Afra, Hajar, et al.
Publicado: (2022)

Calprotectin: a novel biomarker for the diagnosis of pleural effusion
por: Sánchez-Otero, N, et al.
Publicado: (2012)

Serum Calprotectin: A Potential Biomarker for Neonatal Sepsis
por: Decembrino, Lidia, et al.
Publicado: (2015)

Calprotectin could be a potential biomarker for acute appendicitis
por: Ambe, Peter C., et al.
Publicado: (2016)

Calprotectin: An Ignored Biomarker of Neutrophilia in Pediatric Respiratory Diseases
por: Chatziparasidis, Grigorios, et al.
Publicado: (2021)

Calprotectin, Biomarker of Depression in Patients with Inflammatory Bowel Disease?
por: Iordache, Miorita Melina, et al.
Publicado: (2023)

Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection()()
por: O'Moráin, N, et al.
Publicado: (2022)

Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study)
por: García de Guadiana-Romualdo, Luis, et al.
Publicado: (2021)

Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department
por: Bauer, Wolfgang, et al.
Publicado: (2021)

Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy?
por: Tabur, Suzan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_foq3hms4ucmccso5eukpkoe5bq